Active · per the CBE, 30 October 2026

MEDIDEV

BE1008121493

Rechtspersoon Private limited company 1 establishment

Alsembergsesteenweg 77, 1630 Linkebeek

Active for

2 year, 6 months

Financials

Financial year 2025

MEDIDEV from Linkebeek, company number BE1008121493, closed financial year 2025 with a result of € 65,312 after tax. For that financial year MEDIDEV recorded a gross margin of € 85,511 and equity of € 162,199. Compared with financial year 2024, the result moved from € 94,552 to € 65,312. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 162,199

▲ 66% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 65,312

▼ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 154,350

▲ 122% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

1 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 2,131

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,714

▲ € 2,605 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 26,583

▼ 9% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
20242025Change 2024 → 2025
Gross margin € 121,533 € 85,511 ▼ 30%
Profit after taxes € 94,552 € 65,312 ▼ 31%
Equity € 97,719 € 162,199 ▲ 66%
Total debts € 31,696 € 35,776 ▲ 13%
Cash € 69,547 € 154,350 ▲ 122%
Retained profit € 93,719 € 158,199 ▲ 69%
Dividend € 833 € 833
Balance sheet total € 129,416 € 197,974 ▲ 53%

Key figures of MEDIDEV, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDIDEV?

What happened at MEDIDEV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 65,312 (▼ 31% vs 2024). Source: NBB ↗
  • New establishment in Oudergem. KBO
  • Start of the company according to the CBE. KBO

In short

From € 94,552 profit in 2024 to € 65,312 profit in 2025.

Paid € 45,413 in corporate taxes since 2024.

Best year ever: 2024, with € 94,552 profit.

Paid out € 1,666 in dividends to the owners in total.

Establishments

Establishment units

Physical locations of this company

Registered office

Alsembergsesteenweg 77

1630 Linkebeek

2.358.942.406

Vorstlaan 205 box 2.3

1160 Oudergem

Active since 8 April 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1008.121.493
VAT number
BE 1008.121.493
Registered office
Alsembergsesteenweg 77, 1630 Linkebeek
Names & denominations
MEDIDEV
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
8 April 2024
Peppol
Active · Active since 25 Dec 2025

Frequently asked questions

What is the address of MEDIDEV?
The registered office of MEDIDEV is located at Alsembergsesteenweg 77, 1630 Linkebeek.
Is MEDIDEV still active?
Yes. According to the CBE (30 October 2026) MEDIDEV is active, legal situation “Normale toestand”, started on 8 April 2024.
Is MEDIDEV registered on Peppol?
Yes, MEDIDEV is registered on the Peppol network with ID 0208:1008121493.
What is the enterprise number of MEDIDEV?
The enterprise number of MEDIDEV is BE1008121493.
When was MEDIDEV founded?
MEDIDEV was founded on 8 April 2024.
Is MEDIDEV a reliable company?
Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 April 2024; 2 annual accounts filed, latest fiscal year 2025.